相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New drugs creating new challenges in acute myeloid leukemia
Ing S. Tiong et al.
GENES CHROMOSOMES & CANCER (2019)
New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise
Stephan R. Bohl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
Richard F. Schlenk et al.
BLOOD (2019)
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Nese Cakmak-Goeruer et al.
LEUKEMIA (2019)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CARs versus BiTEs: A Comparison between T Cell-Redirection Strategies for Cancer Treatment
Clare Y. Slaney et al.
CANCER DISCOVERY (2018)
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study
Alexander E. Perl et al.
LANCET ONCOLOGY (2017)
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
R. M. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Katherine Tarlock et al.
CLINICAL CANCER RESEARCH (2017)
Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy
Maria-Elisabeth Goebeler et al.
LEUKEMIA & LYMPHOMA (2016)
Characterization of a biopharmaceutical protein and evaluation of its purification process using automated capillary Western blot
Dong Xu et al.
ELECTROPHORESIS (2015)
Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
Carolina Berger et al.
CANCER IMMUNOLOGY RESEARCH (2015)
ASP2215, a novel FLT3/AXL inhibitor: Preclinical evaluation in acute myeloid leukemia (AML).
Masamichi Mori et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system
Jin-Qiu Chen et al.
ANALYTICAL BIOCHEMISTRY (2013)
Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia
Eric I. Zimmerman et al.
BLOOD (2013)
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
Peter J. K. van Meer et al.
MABS (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Unexpected Hematologic Effects of Biotherapeutics in Nonclinical Species and in Humans
Nancy E. Everds et al.
TOXICOLOGIC PATHOLOGY (2013)
Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
Thomas Fischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia
Soheil Meshinchi et al.
CLINICAL CANCER RESEARCH (2009)
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
Rafael Ponce et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
Eugen Koren et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival
Yoshikane Kikushige et al.
JOURNAL OF IMMUNOLOGY (2008)
Current concepts - Drug-induced immune thrombocytopenia
Richard H. Aster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage
DT Avery et al.
JOURNAL OF IMMUNOLOGY (2005)
Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia
JM Bertho et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2001)
分享论文
